Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants.

Autor:	Savostyanov K; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Pushkov A; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Zhanin I; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Mazanova N; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Pakhomov A; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Trufanova E; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Alexeeva A; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Sladkov D; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Kuzenkova L; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia., Asanov A; Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow 119991, Russia., Fisenko A; FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia.
Jazyk:	angličtina
Zdroj:	Genes [Genes (Basel)] 2023 Oct 28; Vol. 14 (11). Date of Electronic Publication: 2023 Oct 28.
DOI:	10.3390/genes14112016
Abstrakt:	Background: Fabry disease (FD) is a rare hereditary multisystem disease caused by variants of the GLA gene. Determination of GLA gene variants and identification of genotype-phenotype correlations allow us to explain the features of FD associated with predominant damage of one or another system, both in the classical and atypical forms of FD, as well as in cases with late manifestation and involvement of one of the systems. Methods: The study included 293 Russian patients with pathogenic variants of the GLA gene, which were identified as a result of various selective screening programs. Screening was carried out for 48,428 high-risk patients using a two-step diagnostic algorithm, including the determination of the concentration of the biomarker lyso-Gb3 as a first-tier test. Screening of atypical FD among patients with HCM was carried out via high-throughput sequencing in another 2427 patients. Results: 102 (0.20%) cases of FD were identified among unrelated patients as a result of the study of 50,855 patients. Molecular genetic testing allowed us to reveal the spectrum and frequencies of 104 different pathogenic variants of the GLA gene in 293 examined patients from 133 families. The spectrum and frequencies of clinical manifestations in patients with FD, including 20 pediatric patients, were described. Correlations between the concentration of the lyso-Gb3 biomarker and the type of pathogenic variants of the GLA gene have been established. Variants identified in patients with early stroke were described, and the association of certain variants with the development of stroke was established. Conclusions: The results of a large-scale selective FD screening, as well as clinical and molecular genetic features, in a cohort of 293 Russian patients with FD are described.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu